UF researchers create method to predict leukemia drug complications
UF researchers have created a way to use genetics to predict leukemia patients’ risk for complications from chemotherapy drug toxicity.
UF researchers have created a way to use genetics to predict leukemia patients’ risk for complications from chemotherapy drug toxicity.
In an interview with OncLive, Mansi Dalal, M.D., discussed graft failure risk factors in pediatric non-malignant disorders.
In an interview with OncLive, Jordan Milner, M.D., discussed hematopoietic stem cell transplant in pediatric patients with severe aplastic anemia.
A new study of glioblastoma suggests that two specific cancer cell mutations may work together to help hide tumors from the immune system.
In an OncLive podcast, Drs. Milner, Dalal and Ligon discussed stem cell transplant methods, results and risk factors in pediatric patients.
In an interview with OncLive, John Ligon, M.D., discussed findings from a study on the use of mediports to deliver CAR T-cell therapy.
In an interview with OncLive, Jonathan Chatzkel, M.D., discussed the phase Ib/II IMMCO-1 trial in mCRPC and other immunologically cold tumors.
Stephanie Staras, Ph.D., aims to reduce cancer risk by addressing barriers to HPV vaccination.
Research from a team including Matthew Eddy, Ph.D., reveals the mechanisms behind a long-neglected process in cellular communication.
The new research sheds light on the complex interactions between cancer cells and the immune system.